Retraction: The ratio of circulating regulatory T cells (Tregs)/Th17 cells is associated with acute allograft rejection in liver transplantation (PLOS One 9:11 (e112135) DOI: 10.1371/journal.pone.0112135);The ratio of circulating regulatory T cells (Tregs)/Th17 cells is associated with acute allograft rejection in liver transplantation

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Wang, Ying ^a,b   Zhang, Min ^b   Liu, Zhen Wen ^b   Ren, Wei Guo ^c   Shi, Yan Chao ^a,b   Sun, Yan Ling ^b   Wang, HongBo ^b   Jin, Lei ^b   Wang, Fu Sheng ^b   Shi, Ming ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING 302 HOSPITAL   (China)

^c THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; INTERLEUKIN 10; KI 67 ANTIGEN; DIFFERENTIATION ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER INJURY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REGULATORY T LYMPHOCYTE; REJECTION ACTIVITY INDEX; SCORING SYSTEM; TH17 CELL; ACUTE DISEASE; ALLOGRAFT; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ACUTE DISEASE; ADULT; ALLOGRAFTS; ANTIGENS, DIFFERENTIATION; CD4 LYMPHOCYTE COUNT; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84910651062     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0222348     Document Type: Erratum

References (45)

1. O'Leary JG, Lepe R, Davis GL (2008) Indications for liver transplantation. Gastroenterology 134: 1764-1776.
2. Blöcher S, Wilker S, Sucke J., Pfeil U, Dietrich H, et al. (2007) Acute rejection of experimental lung allografts: characterization of intravascular mononuclear leukocytes. Clin Immunol 124: 98-108.
3. Wood KJ (2011) Regulatory T Cells in Transplantation. Transpl Proc 43: 2135-2136.
4. Keller MR, Burlingham WJ (2011) Loss of tolerance to self after transplant. Semin Immunopathol 33: 105-110.
5. Long E, Wood KJ (2009) Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 88: 1050-1056.
6. Issa F, Hester J, Goto R., Nadig SN, Goodacre TE, et al. (2010) Ex Vivo-Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model. Transplantation 90: 1321-1327.
7. Sakaguchi S, Yamaguchi T, Nomura T., Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
8. Gorantla VS, Schneeberger S, Brandacher G., Sucher R, Zhang D, et al. (2010) T Regulatory Cells and Transplantation Tolerance. Transplant Rev 24: 147-159.
9. He Q, Fan H, Li J.Q., Qi HZ (2011) Decreased Circulating CD4+CD25 highFoxp3+ T Cells During Acute Rejection in Liver Transplant Patients. Transpl Proc 43: 1696-1700.
10. Joffre O, Santolaria T, Calise D., Saati TA, Hudrisier D, et al. (2008) Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14: 88-92.
11. Zhang X, Li M, Lian D., Zheng X, Zhang ZX, et al. (2008) Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol 127: 313-321.
12. Li Y, Koshiba T, Yoshizawa A., Yonekawa Y, Masuda K, et al. (2004) Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4: 2118-2125.
13. Li Y, Zhao X, Cheng D., Haga H, Tsuruyama T, et al. (2008) The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 86: 1837-1843.
14. Zuber J, Brodin-Sartorius A, Lapidus N., Patey N, Tosolini M, et al. (2009) FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol Dial Transplant 24: 3847-3854.
15. Heidt S, Segundo DS, Chadha R, Wood KJ (2010) The impact of TH17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant 15: 456-461.
16. Hammerich L, Heymann F, Tacke F (2011) Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011: 1-12.
17. Burrell BE, Bishop DK (2010) Th17 cells and transplant acceptance. Transplantation 90: 945-948.
18. Kim HY, Cho ML, Jhun J.Y., Byun JK, Kim EK, et al. (2013) The imbalance of T helper 17/regulatory T cells and memory B cells during the early posttransplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression. Immunology 138: 124-133.
19. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, et al. (2008) A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205: 3133-3144.
20. Antonysamy MA, Fanslow WC, Fu F, Li W., Qian S, et al. (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162: 577-584.
21. Loong CC, Hsieh HG, Lui W.Y., Chen A., Lin CY (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197: 322-332.
22. Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Pons-Romero F (2009) Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl 15: 629-633.
23. Vanaudenaerde BM, Dupont LJ, Wuyts W.A., Verbeken EK, Meyts I, et al. (2006) The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 27: 779-787.
24. Chen H, Wang W, Xie H., Xu X, Wu J, et al. (2009) A pathogenic role of IL-17 at the early stage of corneal allograft rejection. Transpl Immunol 21: 155-161.
25. Tang JL, Subbotin VM, Antonysamy M.A., Troutt AB, Rao AS, et al. (2001) Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72: 348-350.
26. Crispim JC, Grespan R, Martelli-Palomino G, Rassi D.M., Costa RS, et al. (2009) Interleukin-17 and kidney allograft outcome. Transplant Proc 41: 1562-1564.
27. Abadja F, Atemkeng S, Alamartine E., Berthoux F, Mariat C (2011) Impact of Mycophenolic Acid and Tacrolimus on Th17-Related Immune Response. Transplantation 92: 396-403.
28. Deteix C, Attuil-Audenis V, Duthey A., Patey N, McGregor B, et al. (2010) Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 184: 5344-5351.
29. Korn T, Bettelli E, Oukka M., Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
30. Bettelli E, Carrier Y, Gao W., Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
31. Deknuydt F, Bioley G, Valmori D., Ayyoub M (2009) IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 131: 298-307.
32. (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25: 658-663.
33. + cd T cell subsets in acute liver allograft rejection. Transpl Immunol 29: 118-122.
34. Stenard F, Nguyen C, Cox K., Kambham N, Umetsu DT, et al. (2009) Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 13: 70-80.
35. Koshiba T, Li Y, Takemura M., Wu Y, Sakaguchi S, et al. (2007) Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 17: 94-97.
36. Li J, Lai X, Liao W., He Y, Liu Y, et al. (2011) The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immuno-pharmacol 11: 962-967.
37. Hanidziar D, Koulmanda M (2010) Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant 15: 411-415.
38. + regulatory T cells that prevent allograft rejection: Potential avenues for cellular therapy. Transplantation 86: 578-589.
39. Afzali B, Lombardi G, Lechler R.I., Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148: 32-46.
40. Loong CC, Hsieh HG, Lui W.Y., Chen A., Lin CY (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197: 322-332.
41. Yoshida S, Haque A, Mizobuchi T., Iwata T, Chiyo M, et al. (2006) Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 6: 724-735.
42. Li J, Simeoni E, Fleury S., Dudler J, Fiorini E, et al. (2006) Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur J Cardiothorac Surg 29: 779-783.
43. Fan H, Li LX, Han D.D., Kou JT, Li P, et al. (2012) Increase of peripheral Th17 lymphocytes during acute cellular rejection in liver transplant recipients. Hepatobiliary Pancreat Dis Int 11: 606-611.
44. Afzali B, Mitchell PJ, Edozie F.C., Povoleri GAM, Dowson SE, et al. (2013) CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol 43: 2043-2054.
45. Pesenacker AM, Bending David, Ursu S, Wu Q.i., Nistala K., et al. (2013) CD161 defines the subset of FoxP31 T cells capable of producing proinflammatory cytokines. Blood 121: 2647-2658.